Back to CITIGROUP INC CITIGROUP INC

IBOIBO
5 quarters

Position history for CITIGROUP INCCITIGROUP INC's holdings in IMPACT BIOMEDICAL INC

Yes. Citigroup holds 1 shares of IBO (Impact Biomedical) as of its Q2 2026 13F filing. It reduced the position by 352 shares (-99.7%) from Q1 2026. Citigroup has held IBO since Q2 2025, across 5 quarterly 13F filings.

Current Value

$0

Current Shares

1

Total Value Change

-$5,685

Total Shares Change

-8,783

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1
-99.7%
$00.0%$5.81
0
2026-Q1
Increased
353
+352x
$2120.0%$7.57
12
2025-Q4
Decreased
1
-100.0%
$10.0%$6.37
0
2025-Q3
Decreased
3,396
-61.3%
$2,2580.0%$8.39
0
2025-Q2
New
8,784
-
$5,6850.0%$8.17
24

Other major holders of IBO: GEODE CAPITAL MANAGEMENT, LLC, VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used